Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lobo, Miriam
173  Ergebnisse:
Personensuche X
?
1

Evaluation of Breast Cancer Patients with Genetic Risk in a..:

Lobo, Miriam ; López‐Tarruella, Sara ; Luque, Soledad...
Journal of Genetic Counseling.  27 (2017)  4 - p. 854-862 , 2017
Link: https://doi.org/10.1007/..
 
?
2

Erratum to: Frequency of germline DNA genetic findings in a..:

González-Rivera, Milagros ; Lobo, Miriam ; López-Tarruella, Sara...
Breast Cancer Research and Treatment.  165 (2017)  2 - p. 471-471 , 2017
Link: https://doi.org/10.1007/..
 
?
3

Frequency of germline DNA genetic findings in an unselected..:

González-Rivera, Milagros ; Lobo, Miriam ; López-Tarruella, Sara...
Breast Cancer Research and Treatment.  156 (2016)  3 - p. 507-515 , 2016
Link: https://doi.org/10.1007/..
 
?
4

Multicenter analysis of neoadjuvant docetaxel, carboplatin,..:

Echavarria, Isabel ; Granja, Mónica ; Bueno, Coralia...
Breast Cancer Research and Treatment.  162 (2016)  1 - p. 181-189 , 2016
Link: https://doi.org/10.1007/..
 
?
5

Cyclin Kinase Inhibitors in Breast Cancer: From Bench to Be..:

Torres, Gabriela ; Echavarría, Isabel ; Lobo, Miriam..
Current Breast Cancer Reports.  6 (2014)  2 - p. 79-87 , 2014
Link: https://doi.org/10.1007/..
 
?
6

Validation of the CoVID-TE model as a tool to predict throm..:

Sánchez Cánovas, Manuel ; Fernández Garay, David ; Gómez Martínez, Francisco...
Clinical and Translational Oncology.  26 (2023)  1 - p. 171-177 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Immune checkpoint inhibitor-associated thrombosis in patien..:

Sánchez Cánovas, Manuel ; Fernández Garay, David ; Adoamnei, Evdochia...
Clinical and Translational Oncology.  25 (2023)  10 - p. 3021-3031 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarke..:

Núñez Abad, Martín ; Calabuig-Fariñas, Silvia ; Lobo de Mena, Miriam...
Cancers.  14 (2022)  2 - p. 307 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Update on systemic treatment in early triple negative breas..:

Núñez Abad, Martín ; Calabuig-Fariñas, Silvia ; Lobo de Mena, Miriam...
Therapeutic Advances in Medical Oncology.  13 (2021)  - p. 175883592098674 , 2021
Link: https://doi.org/10.1177/..
 
?
10

Immune checkpoint inhibitors-associated thrombosis in patie..:

Cánovas, Manuel Sánchez ; Garay, David Fernández ; Moran, Laura Ortega...
Clinical and Translational Oncology.  24 (2022)  10 - p. 2010-2020 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Postural Alterations in Breast Cancer Patients Undergoing C..:

Elía, Juana María ; Puerta de Diego, Rocío ; Ezzedine, Aida...
JSM Physical Medicine and Rehabilitation, 2022, vol. 6, num. 1, p. 1018-1016.  , 2023
Link: https://hdl.handle.net/1..
 
?
12

Valoración e intervención nutricional en pacientes oncológi..:

Muresan, Bianca Tiabita ; Jiménez Portilla, Ana ; Artero, Ana...
Nutricion Hospitalaria, 2022, vol. 39, num. 6, p. 1316-1324.  , 2022
Link: https://hdl.handle.net/1..
 
?
13

Immune checkpoint inhibitor-associated thrombosis in patien..:

Sánchez Cánovas, Manuel ; Fernández Garay, David ; Adoamnei, Evdochia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462495/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Validation of the CoVID-TE model as a tool to predict throm..:

Sánchez Cánovas, Manuel ; Fernández Garay, David ; Gómez Martínez, Francisco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257483/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
15

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarke..:

Núñez Abad, Martín ; Calabuig-Fariñas, Silvia ; Lobo de Mena, Miriam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773553/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15